Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155374 | SCV000205061 | likely benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Ser797Phe in Exon 23 of MYO1A: This variant is not expected to have clinical sig nificance because it has been identified in 0.7% (47/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs113470661). |
Genomic Diagnostic Laboratory, |
RCV000155374 | SCV000297077 | benign | not specified | 2015-07-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000155374 | SCV000311038 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000155374 | SCV000700568 | benign | not specified | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000958198 | SCV000730555 | benign | not provided | 2021-02-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24875298, 25262649, 24616153, 12736868) |
Labcorp Genetics |
RCV000958198 | SCV001105025 | benign | not provided | 2018-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000958198 | SCV004133498 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | MYO1A: BP4, BS2 |
Clinical Genetics, |
RCV000155374 | SCV001919353 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000155374 | SCV001965674 | benign | not specified | no assertion criteria provided | clinical testing |